| scholarly article | Q13442814 |
| P356 | DOI | 10.1007/S12026-017-8897-Z |
| P698 | PubMed publication ID | 28116653 |
| P50 | author | Yair Levy | Q73255332 |
| P2093 | author name string | David Tanne | |
| Pnina Rotman-Pikielny | |||
| Idan Goren | |||
| Narin-Nard Carmel-Neiderman | |||
| P2860 | cites work | Seronegative antiphospholipid syndrome | Q24674194 |
| Antiphospholipid antibodies and subsequent thrombo-occlusive events in patients with ischemic stroke | Q28167141 | ||
| High thrombosis rate after fetal loss in antiphospholipid syndrome: effective prophylaxis with aspirin | Q28185196 | ||
| Prognosis of cerebral vein and dural sinus thrombosis: results of the International Study on Cerebral Vein and Dural Sinus Thrombosis (ISCVT) | Q28246110 | ||
| International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS) | Q28292418 | ||
| Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients | Q33341941 | ||
| A retrospective review of 61 patients with antiphospholipid syndrome. Analysis of factors influencing recurrent thrombosis | Q33500954 | ||
| Towards improved criteria for the antiphospholipid syndrome | Q33504235 | ||
| Predictors of deteriorating cerebral infarct: role of inflammatory mechanisms. Would its early treatment be useful? | Q34178270 | ||
| Antiphospholipid syndrome; its implication in cardiovascular diseases: a review | Q34331685 | ||
| Investigation of antiphosphatidyl-serine antibody and antiphosphatidyl-inositol antibody in ischemic stroke patients | Q34442697 | ||
| Pathogenesis of antiphospholipid antibodies: impairment of fibrinolysis and monocyte activation via the p38 mitogen-activated protein kinase pathway | Q36329980 | ||
| Antiphospholipid syndrome: laboratory detection, mechanisms of action and treatment. | Q37842673 | ||
| beta(2)-Glycoprotein 1-dependent anticardiolipin antibodies and risk of ischemic stroke and myocardial infarction: the honolulu heart program | Q40693493 | ||
| Study of phosphatidylserine-dependent anti-prothrombin antibody in cerebral infarction | Q43580595 | ||
| Ischemic stroke in young age | Q43843688 | ||
| Antiphospholipid antibodies and stroke in young women | Q44168396 | ||
| Thrombogenicity of beta 2-glycoprotein I-dependent antiphospholipid antibodies in a photochemically induced thrombosis model in the hamster | Q44189585 | ||
| Hyperhomocysteinemia, low folate and vitamin B12 concentrations, and methylene tetrahydrofolate reductase mutation in cerebral venous thrombosis | Q44932714 | ||
| Antiphosphatidylethanolamine antibodies in recurrent early pregnancy loss and mid-to-late pregnancy loss | Q44967064 | ||
| Thrombophilic screening in young patients (< 40 years) with idiopathic ischemic stroke: a controlled study | Q46061041 | ||
| Clinical relevance of multiple antibody specificity testing in anti-phospholipid syndrome and recurrent pregnancy loss | Q46338955 | ||
| Antiphospholipid antibody ELISAs: survey on the performance of clinical laboratories assessed by using lyophilized affinity-purified IgG with anticardiolipin and anti-beta2-Glycoprotein I activity | Q47588734 | ||
| Cytokine-induced inflammation and long-term stroke functional outcome. | Q48237157 | ||
| High prevalence of antiphosphatidylinositol antibodies in young patients with cerebral ischemia of undetermined cause | Q48398617 | ||
| IL-6: an early marker for outcome in acute ischemic stroke | Q48899503 | ||
| Anticardiolipin antibodies are an independent risk factor for first ischemic stroke. The Antiphospholipid Antibodies in Stroke Study (APASS) Group | Q70514603 | ||
| Antiphosphatidyl serine antibodies are independently associated with ischemic stroke | Q73114357 | ||
| Outcome of patients with anticardiolipin antibodies: a 10 year follow-up of 52 patients | Q74284472 | ||
| Prevalence rates of antiphospholipid antibodies in ischemic stroke patients | Q79175154 | ||
| Interleukin-6 and soluble intercellular adhesion molecule-1 in acute brain ischaemia | Q80802078 | ||
| Clinical significance of anti-annexin V antibody in acute cerebral ischemia | Q83749241 | ||
| P433 | issue | 2 | |
| P304 | page(s) | 470-476 | |
| P577 | publication date | 2017-04-01 | |
| P1433 | published in | Immunologic Research | Q15754981 |
| P1476 | title | Classical and additional antiphospholipid antibodies in blood samples of ischemic stroke patients and healthy controls. | |
| P478 | volume | 65 |
| Q33695145 | Editorial: Cutting edge in systemic lupus erythematosus | cites work | P2860 |
Search more.